Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.41 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PGK1 | P00558 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18335098 | 0.80 | EGLN1 (0.44) | CHRNB2CHRNA2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL19063455 | 0.77 | ALDH1A1 (0.40) | EGLN1KDM4EALDH1A1POLBGRM5 | |
| SCHEMBL1008733 | 0.74 | KDM4E (0.49) | PDGFRBPDGFRAKDM4EALDH1A1POLB | |
| SCHEMBL1010354 | 0.72 | GRM5 (0.46) | CHRNB2CHRNB4CHRNA3KDM4EALDH1A1 | |
| SCHEMBL19171926 | 0.72 | HTT (0.40) | CHRNB2CHRNA2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL19063445 | 0.72 | EGLN1 (0.49) | CHRNB2CHRNA2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL18335115 | 0.72 | CHRNB2 (0.39) | CHRNB2CHRNA2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL28162717 | 0.70 | KDM4E (0.40) | PDGFRBPDGFRAKDM4EALDH1A1POLB | |
| SCHEMBL1007852 | 0.70 | KDM4E (0.34) | KDM4EALDH1A1POLBGRM5 | |
| SCHEMBL18335128 | 0.69 | CHRNB2 (0.37) | CHRNB2CHRNA2CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10231454-B2 | Fungicidal or bactericidal composition, and method for controlling diseases | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-03-19 | — | — | US | disclosed |
| US-20180220655-A1 | FUNGICIDAL OR BACTERICIDAL COMPOSITION, AND METHOD FOR CONTROLLING DISEASES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-08-09 | — | — | US | disclosed |
| US-9974305-B2 | Fungicidal or bactericidal composition, and method for controlling diseases | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20170188580-A1 | FUNGICIDAL OR BACTERICIDAL COMPOSITION, AND METHOD FOR CONTROLLING DISEASES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180220655-A1 | FUNGICIDAL OR BACTERICIDAL COMPOSITION, AND METHOD FOR CONTROLLING DISEASES | NOX3, TH, CBR3 | CHRNB2 1827/4885CHRNA2 2894/4885CHRNB4 1606/4885 |
| US-10231454-B2 | Fungicidal or bactericidal composition, and method for controlling diseases | NOX3, TH, CBR3 | CHRNB2 1827/4885CHRNA2 2894/4885CHRNB4 1606/4885 |
| US-20170188580-A1 | FUNGICIDAL OR BACTERICIDAL COMPOSITION, AND METHOD FOR CONTROLLING DISEASES | NOX3, TH, CBR3 | CHRNB2 1827/4885CHRNA2 2894/4885CHRNB4 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.